Is PHVS or PMN more undervalued in 2026?

CirclFi compares Pharvaris N.V. (PHVS) and ProMIS Neurosciences Inc. (PMN) using 13 institutional-grade valuation models. PHVS has a Quality of Company score of 3.9/10 while PMN scores 4.2/10.

Which is a better buy — PHVS or PMN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PHVS and PMN valuations compare?

PHVS at $30.16 and PMN at $10.81 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PHVS vs PMN Valuation Comparison 2026 — Intrinsic Value Analysis

PHVS

Pharmaceutical Preparations

Pharvaris N.V.

Quality

3.9

out of 10

Value Trap

SAFE

Price

$30.16

Last close

Models

7/13

Active

PMN

Pharmaceutical Preparations

ProMIS Neurosciences Inc.

Quality

4.2

out of 10

Value Trap

LOW

Price

$10.81

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	PHVS Fair Value	PHVS Upside	PMN Fair Value	PMN Upside
Bayesian DCF	Intrinsic	$10.80	-64.2%	$6.72	-37.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$4.55	-84.9%	$10.85	+0.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PHVS vs PMN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PHVS vs PMN — Which Stock Is More Undervalued?

PMN scores higher with a 4.2/10 quality rating vs PHVS's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Pharvaris N.V. (PHVS) and ProMIS Neurosciences Inc. (PMN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PHVS currently trades at $30.16 with a QOC of 3.9/10, while PMN trades at $10.81 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).